AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Understanding what a beginner investment portfolio looks like is crucial for new investors. Learn the basics to kickstart your investment journey.
27,003 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
MicroStrategy’s once-buzzing retail following on Reddit is fading fast as the company sells crypto to fund dividends ...
Over the last decade, the iShares S&P 100 ETF led large-cap funds with outsized gains, but 2026’s early volatility hi...
Investors are split as talks on a possible Iran accord fuel optimism and a warning that the iran deal could actually ...
Bitmine has purchased 52,203 ETH for roughly $90 million, boosting its stake to about 4.7% of ETH's circulating suppl...
A new ETF design keeps protection in place month after month, preventing panic selling during dips by resetting hedge...
A high-net-worth parent in his 40s faces a tough choice: retire early or stay employed to support his kids’ future. M...
Amazon stock fell about 3% on Friday as macro uncertainty and doubts about a $200B AI capital plan for 2026 weigh on ...
Microsoft’s stock has drifted lower this year even as its AI and cloud businesses show stronger momentum. This piece ...
A 64-year-old investor with a traditional IRA totaling $1.1 million pivots to three Dividend Kings to weather renewed...
Jim Cramer advised switching away from speculative tech toward industrial stalwarts, naming FedEx, Honeywell Aerospac...
A Silicon Valley veteran-turned-policy architect leads a rapid, AI-first shift in U.S. defense strategy, intensifying...